[呆住]_老虎社区_美港股上老虎

whywhywhywhy
2022-01-24

[呆住]

Unilever CEO’s Woes Grow With Arrival of Activist Investor Peltz

Peltz’s Trian hedge fund has built a stake in Dove soap ownerCEO Jope’s Unilever now has a fox in he

Unilever CEO’s Woes Grow With Arrival of Activist Investor Peltz

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":630533195,"tweetId":"630533195","gmtCreate":1642981202486,"gmtModify":1642981308222,"author":{"id":3580704334567935,"authorId":3580704334567935,"authorIdStr":"3580704334567935","name":"whywhywhywhy","avatar":"https://static.tigerbbs.com/28195847b88a5c5115f0ab53d2eb35e7","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":8,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":51,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p><span>[呆住]&nbsp;</span></p></body></html>","htmlText":"<html><head></head><body><p><span>[呆住]&nbsp;</span></p></body></html>","text":"[呆住]","highlighted":2,"essential":1,"paper":1,"likeSize":2,"commentSize":14,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/630533195","repostId":1111718257,"repostType":4,"repost":{"id":"1111718257","pubTimestamp":1642980762,"share":"https://www.laohu8.com/m/news/1111718257?lang=&edition=full","pubTime":"2022-01-24 07:32","market":"us","language":"en","title":"Unilever CEO’s Woes Grow With Arrival of Activist Investor Peltz","url":"https://stock-news.laohu8.com/highlight/detail?id=1111718257","media":"Bloomberg","summary":"Peltz’s Trian hedge fund has built a stake in Dove soap ownerCEO Jope’s Unilever now has a fox in he","content":"<html><head></head><body><ul><li>Peltz’s Trian hedge fund has built a stake in Dove soap owner</li><li>CEO Jope’s Unilever now has a fox in henhouse, Jefferies says</li></ul><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/25d73cef7687af31a0b25d2aae0f65b4\" tg-width=\"2000\" tg-height=\"1334\" width=\"100%\" height=\"auto\"/><span>Nelson PeltzPhotographer: Patrick T. Fallon/Bloomberg</span></p><p>A stake that Nelson Peltz’s activist hedge fund has built in Unilever Plc is adding to pressure on the Dove soap maker’s chief executive officer, Alan Jope, after Jope’s failed bid to buy a consumer-health unit from GlaxoSmithKline Plc.</p><p>Peltz’s Trian Fund Management has bought a meaningful stake in London-based Unilever over the past few months, according to people familiar with the matter, who asked not to be identified because the plans are private. The exact size of the stake or Peltz’s intentions couldn’t be immediately learned.</p><p>The emergence of an activist investor is the latest challenge for Jope, who is already reeling from the failed GSK purchase and faces growing pressure to deliver a new strategy. Billionaire Peltz is turning his attention to Unilever after retiring from Procter &amp; Gamble Co.’s board in August after nearly four years that brought several dramatic changes aimed at improving that consumer-goods giant’s performance.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b8aed06bfdc42c678d754ae34a69d62b\" tg-width=\"1000\" tg-height=\"666\" width=\"100%\" height=\"auto\"/><span>Alan JopePhotographer: Bridget Bennett/Bloomberg</span></p><p>“The fox would now appear to be inside the henhouse,”Jefferies analysts led by Martin Deboo wrote Sunday. “The force and temperature of debate around Unilever now looks set to rise by several notches.”</p><p>Trian will likely argue for splitting Unilever’s food business from its household and personal care operations, Deboo wrote, and “further increase the pressure” on Jope and the board.</p><p>Unilever shares recorded their worst weekly loss since the peak of the pandemic selloff in March 2020 after it confirmed on Jan. 16 that it offered 50 billion pounds ($68 billion) for the GSK health-care unit, which includes brands such as Advil and Sensodyne. GSK rejected the bid as too low, and Unilever later said it had no plans to raise the offer. GSK has its own activist investor in the mix, with Elliott Investment Management pushing for changes.</p><p>Unilever shares could benefit from Peltz’s stake-building on Monday. Trian, which was co-founded by Peltz, Ed Garden and Peter May, has a history of pushing for changes at consumer companies, including PepsiCo Inc.,Danone SA, Kraft Foods Inc. and others. Unilever rose less than 1% on Jan. 21, giving it a market valuation of about 94 billion pounds. Its shares had declined about 6.9% in a year.</p><p>CEO Jope’s public defeat came after analysts implored him not to pursue the Glaxo unit. Fund manager Terry Smith called the GSK bid a “near-death experience.” Only days earlier, he had urged Unilever to focus more on fixing its own business rather than seeking to promote the sustainability ethos of brands such as Hellmann’s mayonnaise.</p><p>The Financial Times earlier reported the Trian stake. Representatives for the hedge fund and Unilever declined to comment.</p><p><img src=\"https://static.tigerbbs.com/885c7446547d2d2cd3def40ed490db83\" tg-width=\"1200\" tg-height=\"675\" width=\"100%\" height=\"auto\"/></p><p>It remains to be seen whether Jope’s setback with GSK will prompt the kind of radical changes implemented at Unilever after Kraft Heinz Co.’s failed bid to acquire Unilever in 2017 for $143 billion. That debacle led Unilever to consolidate its headquarters in the U.K., ditch a cumbersome Anglo-Dutch structure, and adopt a more aggressive acquisition strategy.</p></body></html>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Unilever CEO’s Woes Grow With Arrival of Activist Investor Peltz</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUnilever CEO’s Woes Grow With Arrival of Activist Investor Peltz\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-24 07:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2022-01-23/peltz-s-activist-fund-trian-is-said-to-build-stake-in-unilever?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Peltz’s Trian hedge fund has built a stake in Dove soap ownerCEO Jope’s Unilever now has a fox in henhouse, Jefferies saysNelson PeltzPhotographer: Patrick T. Fallon/BloombergA stake that Nelson Peltz...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2022-01-23/peltz-s-activist-fund-trian-is-said-to-build-stake-in-unilever?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UL":"联合利华(英国)","UN":"联合利华(荷兰)","GSK":"葛兰素史克"},"source_url":"https://www.bloomberg.com/news/articles/2022-01-23/peltz-s-activist-fund-trian-is-said-to-build-stake-in-unilever?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1111718257","content_text":"Peltz’s Trian hedge fund has built a stake in Dove soap ownerCEO Jope’s Unilever now has a fox in henhouse, Jefferies saysNelson PeltzPhotographer: Patrick T. Fallon/BloombergA stake that Nelson Peltz’s activist hedge fund has built in Unilever Plc is adding to pressure on the Dove soap maker’s chief executive officer, Alan Jope, after Jope’s failed bid to buy a consumer-health unit from GlaxoSmithKline Plc.Peltz’s Trian Fund Management has bought a meaningful stake in London-based Unilever over the past few months, according to people familiar with the matter, who asked not to be identified because the plans are private. The exact size of the stake or Peltz’s intentions couldn’t be immediately learned.The emergence of an activist investor is the latest challenge for Jope, who is already reeling from the failed GSK purchase and faces growing pressure to deliver a new strategy. Billionaire Peltz is turning his attention to Unilever after retiring from Procter & Gamble Co.’s board in August after nearly four years that brought several dramatic changes aimed at improving that consumer-goods giant’s performance.Alan JopePhotographer: Bridget Bennett/Bloomberg“The fox would now appear to be inside the henhouse,”Jefferies analysts led by Martin Deboo wrote Sunday. “The force and temperature of debate around Unilever now looks set to rise by several notches.”Trian will likely argue for splitting Unilever’s food business from its household and personal care operations, Deboo wrote, and “further increase the pressure” on Jope and the board.Unilever shares recorded their worst weekly loss since the peak of the pandemic selloff in March 2020 after it confirmed on Jan. 16 that it offered 50 billion pounds ($68 billion) for the GSK health-care unit, which includes brands such as Advil and Sensodyne. GSK rejected the bid as too low, and Unilever later said it had no plans to raise the offer. GSK has its own activist investor in the mix, with Elliott Investment Management pushing for changes.Unilever shares could benefit from Peltz’s stake-building on Monday. Trian, which was co-founded by Peltz, Ed Garden and Peter May, has a history of pushing for changes at consumer companies, including PepsiCo Inc.,Danone SA, Kraft Foods Inc. and others. Unilever rose less than 1% on Jan. 21, giving it a market valuation of about 94 billion pounds. Its shares had declined about 6.9% in a year.CEO Jope’s public defeat came after analysts implored him not to pursue the Glaxo unit. Fund manager Terry Smith called the GSK bid a “near-death experience.” Only days earlier, he had urged Unilever to focus more on fixing its own business rather than seeking to promote the sustainability ethos of brands such as Hellmann’s mayonnaise.The Financial Times earlier reported the Trian stake. Representatives for the hedge fund and Unilever declined to comment.It remains to be seen whether Jope’s setback with GSK will prompt the kind of radical changes implemented at Unilever after Kraft Heinz Co.’s failed bid to acquire Unilever in 2017 for $143 billion. That debacle led Unilever to consolidate its headquarters in the U.K., ditch a cumbersome Anglo-Dutch structure, and adopt a more aggressive acquisition strategy.","news_type":1},"isVote":1,"tweetType":1,"viewCount":620,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":6,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}

Unilever CEO’s Woes Grow With Arrival of Activist Investor Peltz

评论（14）

热议股票